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The purpose of this study was to cover the bitter taste of arbidol hydrochloride (ARB) and
develop dry suspension with combination of solid dispersion and flavors. Taste masking
was successfully done by solid dispersion using octadecanol as the carrier by fusion
method. Suspending agents, carriers and other excipients were selected. Differential
scanning calorimetry (DSC) and Fourier transform infrared spectroscopy (FTIR) were per-
formed to identify the physicochemical interaction between drug and carrier, DSC analysis
indicated that ARB was amorphous in the solid dispersion, FTIR spectroscopy showed no
interaction between drug and carrier. Taste masking was evaluated on six volunteers with
a score of 4.9. The results demonstrated successful taste masking. Water was used to study
the in vitro dissolution performance of the three formulations of commercial tablet, capsule
and self-made suspension. The self-made suspension showed a lower and slower release,
the insoluble carrier octadecanol blocked the drug dissolving from the solid dispersion. It
was indicated from the primary stability study, the self-made suspensions were sensitive
to high temperature, high humidity and strong light conditions, they should be stored in
sealed containers away from heat, light and humidity.
© 2015 Shenyang Pharmaceutical University. Production and hosting by Elsevier B.V. All
rights reserved.1. Introduction
ARB (1-methyl-2-phenyl-thiomethyl-3-carboxy-4-dimethyla-
minomethyl-5-hydr-oxy-6-bromoindole hydrochloride mon-
ohydrate) (Fig. 1) is a small indole-derivatives molecule used
for the treatment and prevention of infections by influenza A,
B viruses, A/H1N1 is included [1]. ARB was listed in Russia in
1993and inChina in 2006, for the control of influenzaandother522.
g Pharmaceutical Univer
University. Production anacute respiratory virus infection [24]. It is proved that ARB is
efficient to reduce the duration of illness and to prevent the
development of post-influenza complications [5]. Moreover,
despite years of clinical trials and application reveal that, ARB
show high efficacy, minor adverse effect, and no drug resis-
tance [69]. A major problem in the development of an oral
solid dosage form of ARB is its intensely bitter taste, leading to
poor patient compliance. To overcome the above problem, we
try to develop a bitterness-covered ARB for dry suspension.sity.
d hosting by Elsevier B.V. All rights reserved.
Fig. 1 e Chemical structure of ARB.
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capsules. It is estimated that 50% of the population have
problem of swallowing tablets and capsules, especially the
pediatric and geriatric population [9]. Dry suspension has
been used to address the problem. In addition to good
patient compliance, there are many advantages of dry sus-
pension, such as safety, stability, convenience and ease
absorption.
Without changing its safety and efficacy, a drug's taste has
to be masked and techniques are being adapted to meet this
need, especially for the pediatric and juveniles patients. These
are as follows: taste masking with flavors, taste masking by
granulation, microencapsulation, ion exchange resins, solid
dispersion method, bitterness inhibitor. When single
approach for taste masking is not very successful for highly
bitter drugs, using combination of various taste masking
technologies is found to be a more efficient strategy [9].
Amongst the strategies mentioned, we choose the combina-
tion of flavors with solid dispersion [10].
Solid dispersion have been defined as dispersion of one or
more active ingredients in an inert carrier or matrix at solid
state prepared bymeltingmethod, hot melt extrusion, solvent
evaporation method, spray drying, supercritical fluid precipi-
tation and so on [11,12].
In our study, melting method was chosen owing to their
effective taste masking and ease of industrial production. To
prepare ARB solid dispersion, octadecanol was used as the
carrier, then flavors such as sucrose,mannitol, aspartame and
orange flavor were added.2. Materials and methods
2.1. Materials
Arbidol hydrochloride was purchased from Sichuan Baili
Pharmaceutical Co., Ltd. (China). Arbidol hydrochloride com-
mercial tablet was purchased from Shiyao Group Pharma-
ceutical (Shijiazhuang) Co., Ltd. (China). Arbidol hydrochloride
commercial capsule was purchased from Shijiazhuang Siyao
Co., Ltd. (China). Xanthan, mannitol, orange flavor concen-
tration and aspartame were purchased from Beijing Fengli
Jingqiu Commerce and Trade Co., Ltd. (China). Sodium car-
boxymethyl cellulose and hydroxypropyl cellulose were
kindly supplied by Anhui Sunhere Pharmaceutical Excipients
Co., Ltd. (China). Arabic gum, octadecanol, sucrose, citric acid,poloxamer 188, glyceryl monostearate, sodium dodecyl sul-
fate, pentane sulfonate and ammonium dihydrogen phos-
phate were purchased from Tianjin Bodi Chemical Co. Ltd.
(China). Sunset yellow dye was purchased from Shanghai
Institute Dye Co. (China). PEG6000 and phosphoric acid was
purchased from Tianjin Kermel Chemical Reagent Co., Ltd.
(Tianjin, China). Methanol of chromatographic grade was
purchased fromConcord Technology Co., Ltd. (Tianjin, China).
2.2. Methods
2.2.1. Preparation of solid dispersions
Conventional melting method was used in our work. Several
typical carriers with a low melting point including PEG6000,
citric acid, octadecanol, poloxamer 188 and glyceryl mono-
stearate were evaluated using organoleptic evaluation and
in vitro dissolution study.
Different carriers were heated at 70 C directly to melt
entirely, then the mixture of ARB and sucrose with a ratio of
1:2 was slowly added to the carriers with constantly stirring.
After totally dispersed, the melted mixture was solidified in
an ice-bath under vigorous stirring until forming particles.
After dried at room temperature for 2 h, the final solid
dispersion was crushed, pulverized and screened by 40#
mesh; particles with diameters under the sizewere chosen for
further use.
2.2.2. Organoleptic evaluation [13]
The objective of this study was to conduct and evaluate the
palatability of different formulations of ARB dry dispersion.
Taste evaluation was done on a team of 3 members. Each
volunteer took dispersion equivalent to 100 mg ARB in the
mouth for 15 s and then spit out. The taste score between 1
and 5 was given to evaluate the taste of formulation. Namely,
the scores were set as follows: 1 (Distasteful, equivalent to
ARB taste), 2 (Slightly taste, ARB taste remaining fairly), 3
(Mean, ARB taste remaining to some extent), 4 (slightly tasty,
ARB taste slightly remaining), 5 (Tasty, no taste of ARB).
2.2.3. In vitro dissolution study
The in vitro dissolution testwas studied using a ChP2010 Type2
dissolution apparatus (paddle method), and all the tests were
carried out in triplicate. The temperature of the dissolution
medium (a volume of 900 ml purified water) was maintained
at 37 ± 0.5 C with stirring from a paddle at 75 rpm. A certain
amount of samples equivalent to 100 mg ARB were used in all
of the dissolution tests. At prescheduled time intervals (5, 10,
15, 20, 30, 45, 60 min), samples aliquots were withdrawn and
filtered (0.45 mm membrane, Millipore) immediately, then
replaced with an equal volume of drug-free dissolution fluid.
The sampleswere suitably dilutedwith blank dissolution fluid
and the concentration of ARB was determined using on a UV
spectrophotometer (Beijing Rayleigh Analytical Instrument
Co.) at 257 nm.
2.2.4. Differential scanning calorimetry analysis
Thermal analysis of octadecanol, raw arbidol hydrochloride,
powdered sucrose, physical mixture, and the solid dispersion
of the three substances were performed on a DSC 1 (Metter
Toledo, Greifensee, Switzerland). Samples each 2e5 mg was
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aluminum pan as a reference. The temperature increased
with a heating rate of 10 C/min from 30 C to 230 C under a
nitrogen gas flow.
2.2.5. FTIR spectroscopy
A Bruker Ifs 55 FTIR spectrometer (Bruker, Switzerland)
equippedwith a DTGS detector was used for infrared analysis.
Samples were prepared with KBr disc method (1 mg sample in
100 mg KBr) and examined in the transmission mode. The
scanning range was 400e4000 cm1 and the resolution was
2 cm1.
2.2.6. Selection of suspending agents
Suspending agent was selected by using single factor method.
Arabic gum, xanthan gum, sodium alginate, sodium carbox-
ymethyl cellulose and hydroxypropylmethyl cellulose were
investigated for the ability of suspending using sedimentation
ratio evaluation index.
The sedimentation ratio of the suspensions was deter-
mined by transferring samples equivalent to 100 mg ARB into
a 50 ml stoppered cylinder, made up to volume with distilled
water, shaken vigorously for 1 min and then stored at room
temperature. It was enough to note the sedimentation at in-
tervals of 30 min because ARB suspension was single-dose
packaging. The sedimentation ratio, F (%), was then calcu-
lated using the following formula.
F ¼ 100H/H0
where H is the ultimate height of the sediment and H0 is the
initial height of the suspension [14].
2.2.7. Selection of flavors and colorants
The amount of flavors including aspartame and orange flavor
were chosen by smell and odor; and the amount of colorants
agent depended on the color of the suspension.
2.2.8. Preparation of ARB dry suspension
The ARB solid dispersion using octadecanol as the carrier was
prepared by the method described in Section 2.2.1. The other
components including powderedmannitol, aspartame, arabic
gum, orange flavor, sodium dodecyl sulfate and sunset yellow
dye were passed by 60# mesh and mixed well with the pre-
pared solid dispersion powders. The final dry suspension was
packaged for further quality evaluation.
2.2.9. Determination of ARB content
Analysis of the content of ARB in the suspensions was per-
formed by high performance liquid chromatography (HPLC)
system (Hitachi, Tokyo, Japan) consisting of an isocratic pump
(Model L-2130), an autosampler (Model L-2200), a UV detector
(Model L-2420) (operating at 254 nm) and HPLC System Man-
ager Hitachi Model D-2000 software. A VP-ODS C18 column
(5 mm, 250  4.6 mm) was used with a mobile phase of
methanoleaqueous phase (1.45 g pentane sulfonate and 3.45 gTable 1 e Organoleptic evaluation of ARB solid dispersion with
Carriers PEG6000 Citric acid Poloxam
Mean value 2.6 2.9 2.ammonium dihydrogen phosphate were dissolved in 900 ml
of distilled water, then adjusted to pH 2.50 with phosphoric
acid) (75:25, v/v) at a flow rate of 1ml/minwith a total injection
volume of 20 ml.
Accurate amount of dry suspension was weighed equiva-
lent to a concentration about 0.1 mg/ml of ARB with mobile
phase as the solvent. The content was calculated by the
external standard method. The retention time was about
6.5 min.
2.2.10. Determination of ARB impurities
The chromatographic conditions were the same to the drug
content of ARB, except that the flow rate of the mobile phase
was 0.8 ml/min. Accurate amount of dry suspension was
weighed equivalent to a concentration about 0.5mg/ml of ARB
with mobile phase as the solvent. Area normalization method
was used to calculate the impurities of ARB. The retention
time was about 8.5 min.
2.2.11. Preliminary stability study of the suspensions
The suspensions were exposed to high temperatures of 40 C
and 60 C, relative humidity of 75% and 92.5%, and light of 4500
l for 10 d. Samples were taken at 0 d, 5 d and 10 d separately.3. Results and discussions
3.1. Preparation of ARB dry suspension
In the present study, a combination of flavors with solid
dispersion dry suspension was prepared to mask the bad
taste of ARB. In the method, solid dispersion played an
important role in taste masking, carriers which drugs were
dispersed in created a physical barrier between the drug and
the taste buds, then taste of active could be masked, flavors
and polymers were added to have a more pleasant taste, fla-
vors could reduce the sensitivity of taste buds to bitter,
polymers as viscosity enhancers could complement the taste
masking.
3.1.1. Effect of the carriers in solid dispersion method
In solid dispersion, one or more active ingredients are ho-
mogeneously dispersed in an inert carrier or matrix in solid
state. The easiest and most affordable melting method was
used for preparation of solid dispersion. Carriers with a low
melting point are preferred. In the experiment, PEG6000, citric
acid, poloxamer 188, octadecanol and glyceryl monostearate
were evaluated. All five carriers were selected according to the
organoleptic evaluation with a team of 3 members. The mean
score was shown in Table 1.
Both octadecanol and glyceryl monostearate could effec-
tively cover the intense bitter mask of ARB, but glyceryl
monostearate had an unpleasant odor. Octadecanol was the
best choice. Sucrose was added to the solid dispersion todifferent carriers.
er 188 Octadecanol Glyceryl monostearate
8 4.0 3.9
Table 3 e The sedimentation ratio of suspensions made
up of different suspending agents.
Arabic gum (weight ratio) 5% 10% 15%
Sedimentation ratio 98.7% 100% 100%
Table 2 eOrganoleptic evaluation of ARB solid dispersion
with different ratios.
Drug-sucrose-carrier weight ratios 1:2:2 1:2:4 1:2:6
Mean value 4.1 4.5 4.6
Table 4 e Formulation of dry suspension by solid
dispersion.
Ingredients Quantity (%)
ARB-sucrose-octadecanol solid dispersion
(1:2:4, w/w/w)
70.0
Arabic gum 10.0
Mannitol 15.0
Aspartame 3.0
Orange flavor 1.0
Sodium dodecyl sulfate 0.5
Sunset dye 0.5
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Then drug-sucrose-carrier weight ratios of 1:2:2, 1:2:4 and
1:2:6 were evaluated by organoleptic evaluation and in vitro
dissolution study. The mean value of taste evaluation was
shown in Table 2.
The dissolution of solid dispersion with different drug-
sucrose-carrier weight ratios (1:2:2, 1:2:4, 1:2:6) were per-
formed in purified water and the corresponding profiles were
shown in Fig. 2.
With the increase of the amount of octadecanol, the taste-
covered capability of the solid dispersion improved, but the
dissolution percentages of solid dispersions gradually
decreased. Theweight ratio (1:2:4) of drug-sucrose-carrier was
a better selection.
3.1.2. Effect of different suspending agents
Most suspending agents perform two functions. Besides
acting as a suspending agent they also imparts viscosity to the
solution. Suspending agents form film around particle and
decrease interparticle attraction. Suspending agents also act
as thickening agents. They increase viscosity of the solution,
which is necessary to prevent sedimentation of the suspended
particles as the Stoke's law. A good suspension should have
well developed thixotropy. At rest the solution is sufficient
viscous to prevent sedimentation and thus aggregation or
caking of the particles. When agitation is applied the viscosity
is reduced and provide good flow characteristic from the
mouth of bottle.
In this study, arabic gum, sodium alginate, sodium car-
boxymethyl cellulose and hydroxypropyl cellulose were
investigated for the ability of suspending. Only with arabic
gum as suspending agents, the particles could disperse easily
and uniformly in water. While other suspending agents were
used, the particles stuck together even shaking vigorously.
Arabic gumwas the best choice of suspending agents and final0 10 20 30 40 50 60
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Fig. 2 e Dissolution profiles of ARB solid dispersion with
different drug-sucrose-carrier weight ratios (means ± SD,
n ¼ 3).suspending agent weight ratios of 5%, 10% and 15% were
evaluated using sedimentation ratio evaluation index. The
sedimentation ratio was shown in Table 3. 10% arabic gum
was selected as the optimal suspending agents.
The amount of flavoring and coloring agents were deter-
mined by organoleptic evaluation as follows: aspartame 3%,
orange flavor concentration 1%, sunset yellow dye 0.5%. Along
with other excipients added, the final formulationwas formed
in Table 4.
3.2. Differential scanning calorimetry analysis
The DSC thermograms of ARB, octadecanol, sucrose, solid
dispersion and the corresponding physical mixture of ARB,
sucrose and octadecanol were shown in Fig. 3. The thermo-
gram curves octadecanol exhibited the single endothermic
peaks at around 60 C, and sucrose showed endothermic
peaks at around 189 C. During scanning of ARB, a relatively
broad endotherm ranging from 90 to 150 C was observed,
indicating the loss of crystal water; the observed little peaks at50 100 150 200
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Fig. 3 e DSC curves of the: (A) ARB/sucrose/octadecanol
physical mixture (1:2:4), (B) ARB, (C) octadecanol, (D)
sucrose and (E) ARB/sucrose/octadecanol solid dispersion
(1:2:4).
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showed that the pure drug was polymorphs. The DSC profiles
of the physical mixture of ARB, sucrose and octadecanol were
the combination of three melting processes. The curve of the
solid dispersion showed the absence of ARB peaks, indicating
that ARB might be in amorphous state, both ARB and sucrose
were incorporated in the solid dispersion, octadecanol
covered the bitter taste of ARB.3.3. FTIR spectroscopy
FTIR is often used to investigate any possible chemical in-
teractions between drugs and matrixes in solid dispersions4000 3500 3000 2500 2000 1500 1000 500
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Fig. 4 e FTIR spectra of the: (A) ARB, (B) sucrose, (C) octadecanol,
ARB/sucrose/octadecanol solid dispersion (1:2:4).[15]. In this paper, FTIR was mainly used to study the possible
interactions between ARB and octadecanol in the solid
dispersion. The infrared spectra of ARB, octadecanol, sucrose,
their solid dispersion and physical mixture were shown in
Fig. 4. No additional shifts or peaks was found on comparison
with FTIR spectrum of the solid dispersion and physical
mixture in the existing peaks, which means that there was no
appreciable interaction between the drug and polymer.3.4. Evaluation of dry suspension
Organoleptic properties are important considerations for
development of a solid dosage form that can influence4000 3500 3000 2500 2000 1500 1000 500
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Table 5e Evaluation of dry suspensions prepared by solid
dispersion.
Parameters Solid dispersion
Appearance Yellow particles
Odor Orange flavor
Sedimentation ratio 100.0%
Drug content 99.5%
Impurities 0.18
Taste evaluation 4.9
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Fig. 5 e Dissolution profiles of self-made dry suspension,
commercial capsule and commercial tablet (means ± SD,
n ¼ 3).
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drugs, taste is one of themost important parameter governing
patient compliance [16] and oral administration of bitter drugs
with an acceptable degree of palatability is a key issue for
health care providers especially for pediatric and geriatric [17].
Taste evaluation is the most important index to assess the
formulations prepared by combination of flavors with solid
dispersion. In addition to taste, we also investigated some
other items such as appearance, sedimentation ratio, drugTable 6 e Stability results of the suspensions.
Storage conditions Appearance Con
0 d Yellow particles
40 C
5 d Yellow agglomerates
10 d Yellow agglomerates
60 C
5 d Yellow agglomerates
10 d Yellow agglomerates
RH 75%
5 d Yellow agglomerates 1
10 d Yellow agglomerates 1
RH 92.5%
5 d Yellow agglomerates
10 d Yellow agglomerates
4500 l
5 d Yellow particles 1
10 d Yellow particles 1content and impurities. All the evaluation parameters were
shown in Table 5.
For oral dosage form, in vitro dissolution is important. The
dissolution of commercial tablet, capsule and self-made dry
suspension were performed in water and the corresponding
profiles are shown in Fig. 5.
With a taste evaluation score of 4.9, the self-made formu-
lation successfully covered the bitter taste of ARB.
In comparison with the commercial tablets and capsules,
the self-made formulations which showed a slower and lower
release, around 90% of the drug dissolved within 60 min, it
would increase the residence time of the dosage form in the
gastrointestinal and achieve a prolonged therapeutic effect in
some extent. Further in vivo research would investigate to
compare the absorption of them. The insoluble carrier octa-
decanol blocked the drug dissolving from the solid dispersion.
3.5. Primary stability study of the suspensions
Appearance, drug content, impurities, weight gain were
investigated and the results were shown in Table 6.
After 10 d, the formulation showed a decreased content of
ARB of 93.1% and 90.3%, an increased content of impurities of
10.76% and 15.7% under the high temperature of 40 C and
60 C, respectively. The results showed that the choice of these
excipients maybe not suitable for ARB, studies of active drug-
excipient compatibility will be performed to support our
findings. And weight gained a lot under the high relative hu-
midity of 75% and 92.5%. So the self-made suspensions should
be stored in sealed containers away from heat, light and hu-
midity to keep its properties unchanged.4. Conclusion
In the research, we developed a method which was a com-
bination of solid dispersion with flavors for preparing ARB
dry suspension. It was proved the approach successfully
covered the bitter taste by the organoleptic evaluation.
Octadecanol as carrier in the solid dispersion covered the
bitter taste of ARB effectively, and a better taste producedtent (%) Impurities (%) Weight gain (%)
99.5 0.18 0
93.0 11.38 e
93.1 10.76 e
95.5 13.39 e
90.3 15.7 e
00.1 0.18 1.56
00.7 0.24 1.51
99.7 0.25 14.77
99.9 0.21 14.63
01.3 0.19 e
00.2 0.30 e
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comparison with the commercial tablets and capsules, the
self-made formulations showed a lower and slower release.
The insoluble carrier octadecanol blocked the drug dissolving
from the solid dispersion. The results of primary stability
study showed that the self-made suspensions were very
sensitive to high temperature; they should be stored in sealed
containers away from heat, light and humidity. Similar solid
dispersion techniques could be applied to other poor taste
drugs, which could cover the bitter taste of bitter drugs by
oral administration.r e f e r e n c e s
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